In my last blog, we explored the current state of digital health, and why I believe we are now on ...

Healthcare reforms, shifting market demands, and increasing regulatory pressures are transforming the life sciences industry on a global scale. Patients, ...

As we look toward the New Year, many medical device companies are considering the implications of the recently released UDI ...

“Start Now,” was the advice that Jay Crowley, Senior Advisor, FDA, provided the audience during Clarkston’s What’s Next for UDI webinar on ...

The timeline has begun for medical device companies to implement UDI. Clarkston discusses a few noteworthy changes and exceptions to the final rule.

The 2nd International Summit on GMP, GCP & Quality Control took place recently at the DoubleTree by Hilton Hotel Chicago ...

The annual meeting of the Bio Supply Management Alliance was held on October 8th, 2013, and was well-attended by key ...

In today’s rapidly changing business climate, understanding the regulatory and demographic environment of the medical device industry is only part of the ...

Medical devices play a critical role in the healthcare of Americans. A medical device can be as simplistic as dental ...

On September 18th, 2013, Clarkston co-sponsored and attended Pennsylvania Bio’s Leadership Panel Program’s Fall CEO Roundtable, which brought together executives, ...

The road to market for a novel biotech therapy is among the most expensive, demanding courses for entrepreneurs to undertake, ...

Pharmaceutical giant GSK recently announced the formation of a $50 million venture capital fund, Action Potential Venture Capital (APVC) Limited, ...